Shih-Ching Lo

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yi A Chen, Mark W Kankel, Sam Hana, Shukkwan Kelly Lau, Maria I Zavodszky, Olivia McKissick, Nicole Mastrangelo, Jessica Dion, Bin Wang, Daniel Ferretti, David Koske, Sydney Lehman, Kathryn Koszka, Helen McLaughlin, Mei Liu, Eric Marshall, Attila J Fabian, Patrick Cullen, Galina Marsh, Stefan Hamann, Michael Craft, Jennifer Sebalusky, H Moore Arnold, Rachelle Driscoll, Adam Sheehy, Yi Luo, Sonia Manca, Thomas Carlile, Chao Sun, Kirsten Sigrist, Alexander McCampbell, Christopher E Henderson, Shih-Ching Lo
In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model. Gene therapy (2022)
Sam Hana, Michael Peterson, Helen McLaughlin, Eric Marshall, Attila J Fabian, Olivia McKissick, Kathryn Koszka, Galina Marsh, Michael Craft, Shanqin Xu, Alexander Sorets, Tess Torregrosa, Chao Sun, Chris E Henderson, Shih-Ching Lo
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice. Gene therapy 28 (10-11) (2021)
Tess Torregrosa, Sydney Lehman, Sam Hana, Galina Marsh, Shanqin Xu, Kathryn Koszka, Nicole Mastrangelo, Alexander McCampbell, Christopher E Henderson, Shih-Ching Lo
Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice. Gene therapy 28 (7-8) (2021)

Shih-Ching Lo.css-eqlu8i{font-size:small;padding-left:4px;}